Cover Image

PERFORATED GIST OF THE SMALL INTESTINE . A RARE CAUSE OF ACUTE ABDOMEN . SURGICAL TREATMENT AND ADJUVANT THERAPY.

SRINIVASA KUMARAN .

Abstract


A case of perforated gastrointestinal stromal tumour (GIST)
of small intestine causing acute abdomen is described, with a
brief review of the literature. A male patient presented with
symptoms of acute abdomen. After evaluation, a laparotomy
was performed, where perforation of a tumour in the jejunum
was found. The perforated part along with the tumour was
resected and the cytopathological examination showed that
the tumour was GIST. Postoperatively, the patient received
treatment, using imatinib.Gastrointestinal stromal tumours are
relatively rare and often present with vague symptoms. Their
first clinical manifestation as acute abdomen due to their perforation
is extremely rare. In emergency laparotomy, a R0
resection is required and adjuvant therapy with imatinib must
be considered.
Keyword :Acute abdomen, perforation, GIST, imatinib.


Full Text:

PDF

References


Connolly EM, Gaffney E, Reynolds JV. Gastrointestinal stromal

tumours. Br J Surg 2003;90:1178-1186

Joensuu H, Kindblom LG. Gastrointestinal tumours - a review.

Acta Orthop Scand Suppl 2004;75:62-71

Miettinen M, Lasota J. Gastrointestinal stromal tumours– definition,

clinical, histological, immunohistochemical, and molecular genetic

features and differential diagnosis. Virchows Arch 2001;438:1–

Judson I. Gastrointestinal stromal tumours (GIST): biology and

treatment. Ann Oncol 2002;13 Suppl 4:287-289

Miettinen M, Sarlomo-Rikala M, Lasota J. Gastrointestinal stromal

tumours: recent advances in understanding of their biology. Hum

Pathol 1999;30:1213–1220

Lee CM, Chen HC, Leung TK, Chen YY. Gastrointestinal stromal

tumour: Computer tomographic features. World J Gastroenterol

;10:2417-2418

Ueyama T, Guo KJ, Hashimoto H et al. A clinicopathologic and

immunohistochemical study of gastrointestinal stromal tumours.

Cancer 1992;69:947-955

DeMatteo RP, Lewis JJ, Leung D et al. Two hundred

gastrointestinal stromal tumours: recurrence patterns and prognostic

factors for survival. Ann Surg 2000;231:51–58

Emory TS, Sobin LH, Lukes L et al. Prognosis of gastrointestinal

smooth-muscle (stromal) tumours: dependence on anatomic site.

Am J Surg Pathol 1999;23:82–87

Bucher P, Villiger P, Egger JF et al. Management of

gastrointestinal stromal tumours: from diagnosis to treatment. Swiss

Med Wkly 2004;134:145-153

Fang SH, Dong DJ, Zhang SZ, Jin M. Angiographic findings of

gastrointestinal stromal tumour. World J Gastroenterol

;10:2905-2907

Vander Noot MR 3rd, Eloubeidi MA, Chen VK et al. Diagnosis of

gastrointestinal tract lesions by endoscopic ultrasound-guided

fine-needle aspiration biopsy. Cancer 2004;102:157-163

Gelibter A, Milella M, Ceribelli A et al. PET scanning evaluation

of response to imatinib mesylate therapy in gastrointestinal stromal

tumour (GIST) patients. Anticancer Res 2004;24:3147- 3151

Bucher P, Taylor S, Villiger P, et al. Are there any prognostic

factors for small intestinal stromal tumours? Am J Surg

;187:761-766

Fletcher CD, Berman JJ, Corless C et al. Diagnosis of gastrointestinal

stromal tumours: a consensus approach. Hum Pathol

;33:459-465

Hirota S, Isozaki K, Moriyama Y et al. Gain-of-function mutations

of c-kit in human gastrointestinal stromal tumours. Science

;279:577-580

Corless CL, Fletcher JA, Heinrich MC. Biology of gastrointestinal

stromal tumours. J Clin Oncol 2004;22:3813- 3825

Chen TW, Liu HD, Shyu RY et al. Giant malignant

gastrointestinal stromal tumours: recurrence and effects of treatment

with STI-571. World J Gastroenterol 2005;11:260- 263

Aparicio T, Boige V, Sabourin JC et al. Prognostic

factors after surgery of primary resectable gastrointestinal

stromal tumours. Eur J Surg Oncol 2004;30:1098-1103

Crosby JA, Catton CN, Davis A et al. Malignant gastrointestinal

stromal tumours of the small intestine: a review

of 50 cases from a prospective database. Ann Surg Oncol

;8:50-59

Verweij J, Casali PG, Zalcberg J et al.

Progression-free survival in gastrointestinal stromal

tumours with high-dose imatinib: randomised trial. Lancet

;364:1127-1134


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

An Initiative of The Tamil Nadu Dr MGR Medical University